Skip to content

Sirolimus (Rapamycin), Whole Blood

Also called Rapamycin level

Therapeutic drug monitoring for sirolimus/rapamycin — an mTOR inhibitor used clinically in transplant medicine, and increasingly discussed in longevity circles.

  • Lab price$100.00
  • RetestPer prescribing physician

What your result means

Included because rapamycin has become a prominent longevity topic. Level monitoring matters because the therapeutic window is narrow and side effects are dose-dependent — and because this is genuinely investigational territory for longevity use.

Ranges
Standard
Transplant therapeutic ranges 4–20 ng/mL depending on protocol; longevity protocols use intermittent, much lower exposure
Optimal
There is no established 'optimal' level for longevity use— that's an honest limitation. Clinical ranges apply to transplant indications.

Therapeutic drug levelYour prescriber sets the target. This is monitoring, not optimization.

Order it yourself

One test, drawn at a Quest lab near you. The price is the lab’s, from Marek’s own menu.

Sirolimus (Rapamycin), Whole Blood test
Marek Diagnostics · single test, drawn at Quest
$100.00
Code CAMERON
Order this test

Code CAMERON takes 10% off. Marek’s checkout adds its one-time blood-draw fee to individual tests and shows the total before you pay.

Order it with Lipid Panel (Cholesterol, HDL, LDL, Triglycerides) and ApoB (Apolipoprotein B) (3 tests, one cart)

What moves Sirolimus (Rapamycin), Whole Blood

Level determined by dose, dosing interval, and metabolism (CYP3A4 — grapefruit and many medications interact substantially).

If it’s high: Immunosuppression, mouth ulcers, impaired wound healing, dyslipidemia, and glucose intolerance.

If it’s low: Sub-therapeutic for clinical indications.

Honest framing: rapamycin for longevity is investigational. Animal lifespan data are genuinely striking; human longevity data don't exist yet. If someone chooses to explore it, they should do so with medical supervision and monitoring — which is exactly what this test enables.
The Before-You-Stack Lab Kit cover

The free Before‑You‑Stack Lab Kit

The 12 labs I’d run before any protocol, what each one tells you, add-ons by goal and how to order them yourself. The PDF is yours straight away.

After that it is about two emails a week: a marker, a compound or a protocol. Unsubscribe in one click.

Everything else about Sirolimus (Rapamycin), Whole Blood

What your Sirolimus (Rapamycin), Whole Blood result means

Each possible result, and what to do next

Where did your sirolimus (rapamycin) level fall?

Below the target set for you
In transplant medicine this risks rejection. In off-label longevity use there is no established target at all, which is worth stating plainly.
Within the target set for you
Where your prescriber intended. Trough levels are what is measured, drawn immediately before the next dose.
Above target
Raises the risk of immunosuppression, mouth ulcers, impaired wound healing, dyslipidemia and infection. Worth prompt review.

What to do next. There is no consumer target for this, and that is the honest answer. The intermittent low-dose protocols discussed in longevity circles are explicitly designed to avoid sustained immunosuppression, and they have no validated level. Grapefruit and any CYP3A4 inhibitor — including some supplements on this site, such as berberine and quercetin — raise sirolimus levels meaningfully. That interaction is real and not theoretical.

What can skew the result

2 things can change the reading or the real level

Some change your real level; others only change the reading. Each one says which, and what to do about it.

Trough timingTiming

Reported against a trough range. Timing relative to the dose is the single largest determinant of the number.

Do this: Draw immediately before the next dose.

The value is real but reflects a moment — retime it
CYP3A4 interactionsDrug or supplement

Grapefruit, clarithromycin, azole antifungals and many others raise levels substantially; rifampicin and St John's Wort lower them.

Do this: This is a narrow-window drug — any new medication or supplement needs prescriber review.

A real change — account for the cause

Plan of attack

What to do, in this order
  1. Confirm the number is real

    Trough timing. Reported against a trough range. Timing relative to the dose is the single largest determinant of the number. Draw immediately before the next dose.

  2. Read it with its partner

    Draw at trough. Requires whole blood, not serum. Draw it alongside: Lipid Panel (Cholesterol, HDL, LDL, Triglycerides), ApoB (Apolipoprotein B), HbA1c (Hemoglobin A1c).

  3. Work out which direction is yours

    If it's high — Immunosuppression, mouth ulcers, impaired wound healing, dyslipidemia, and glucose intolerance.
    If it's low — Sub-therapeutic for clinical indications.

  4. Fix it in order: food, then cause, then everything else

    Nutrition. Avoid grapefruit — it inhibits CYP3A4 and raises levels unpredictably. Note the dyslipidemia effect and monitor lipids.
    Lifestyle. Be aware of infection risk and impaired wound healing — relevant around surgery or injury.

  5. Retest

    Per prescribing physician. Change one thing at a time, or the retest can't tell you which thing worked.

Where the optimal range comes from

Therapeutic drug level

Therapeutic drug level. Your prescriber sets the target. This is monitoring, not optimization.

Measured in
Transplant recipients — the only population in which trough targets have been established.
Anchored to
Graft survival against immunosuppression toxicity in transplant indications. No target exists for longevity or off-label use.
Source
Interpretation belongs to the prescriber; see the result-category block on this page.

This is the most honest 'we don't know' on the site and it should stay that way. The trough ranges printed on a sirolimus report were derived to keep transplanted organs alive, which is a different risk-benefit calculation from anything a healthy person is doing. Intermittent weekly dosing — the pattern most longevity protocols use — does not produce a steady-state trough for those ranges to describe in the first place. Unproven is not the same as ineffective; it does mean nobody can tell you what number to aim for, and this page will not pretend otherwise.

What Sirolimus (Rapamycin), Whole Blood measures

And why people check it

What it tells you

Therapeutic drug monitoring for sirolimus/rapamycin — an mTOR inhibitor used clinically in transplant medicine, and increasingly discussed in longevity circles.

Why people check it

Included because rapamycin has become a prominent longevity topic. Level monitoring matters because the therapeutic window is narrow and side effects are dose-dependent — and because this is genuinely investigational territory for longevity use.

What Sirolimus (Rapamycin), Whole Blood means next to other markers

1 pattern worth knowing
Drug level outside range — check the timing before the dose

Lithium or sirolimus level abnormal · relative to the last dose

Both are narrow-therapeutic-window drugs reported against a trough range, and timing relative to the dose is the single largest determinant of the number. A lithium drawn four hours after the dose is far higher than the same person's true trough.

Lithium: exactly 12 hours after the evening dose. Sirolimus: immediately before the next dose. New medications matter enormously — NSAIDs and diuretics raise lithium, CYP3A4 inhibitors raise sirolimus. Tremor, vomiting or confusion on lithium is toxicity and an emergency.

Panels that carry Sirolimus (Rapamycin), Whole Blood

1 panel, prices with code CAMERON

Read it alongside

Related markers, goals and what moves it in the library

The deep read, with sources

What the Sirolimus (Rapamycin), Whole Blood test actually measures, and the references

What Sirolimus (Rapamycin), Whole Blood actually measures — the analyte, and the assay

The specimen is whole blood, not serum, and that is not a technicality. Sirolimus partitions overwhelmingly into red cells, binding FK506-binding protein 12 inside them. A serum or plasma level would measure the small fraction left outside the cells and would vary with hematocrit, so every validated method lyses whole blood first Ivanova 2011.

Two method families are in use and they do not agree. Immunoassays — historically a microparticle enzyme immunoassay, now chemiluminescent and antibody-conjugated formats — use an antibody that also recognizes sirolimus metabolites. LC-MS/MS separates the parent drug from its metabolites and quantifies it against a stable-isotope internal standard Salm 2000 Ivanova 2011.

The immunoassay reads high, and the reason is metabolite cross-reactivity. Comparisons of chromatographic and immunoassay measurement of sirolimus in transplant recipients were performed precisely to quantify that positive bias Salm 2000 Zochowska 2006. A patient switched from one method to the other will see the number change with no change in dose.

Whole blood samples are also less stable than people assume. The stability of sirolimus and everolimus measured by immunoassay in whole blood from kidney transplant patients was studied for this reason Capone 2008 — storage time and temperature move the result, and hemolysis affects analytes measured on the same specimen Koseoglu 2011.

Sirolimus (Rapamycin), Whole Blood: what changes the blood, and what only changes the reading

What changes the sirolimus in you:

  1. The dose and the dosing interval. Sirolimus has a long terminal half-life — on the order of 60 hours in adults — so steady state takes roughly 5 to 7 days after any change, and weekly dosing regimens produce a concentration-time profile nothing like daily transplant dosing.
  2. CYP3A4 and P-glycoprotein. Sirolimus is a substrate for both. Grapefruit juice, ketoconazole, clarithromycin, diltiazem and ritonavir raise levels; rifampicin, carbamazepine and St John's wort lower them.
  3. Hematocrit. Because the drug lives in red cells, a change in hematocrit changes the whole-blood concentration for the same amount of drug in the body.
  4. Hepatic function, which governs clearance.
  5. Food. A high-fat meal changes absorption, which is why consistency with respect to food matters more than whether it is taken with food.

What changes only the reading:

  1. Immunoassay metabolite cross-reactivity, a positive bias that varies between patients because metabolite profiles vary Salm 2000 Zochowska 2006.
  2. A laboratory changing method mid-course, which shifts a series by more than most dose adjustments Lorde 2023.
  3. Drawing at the wrong point in the interval. The whole reference framework is a trough concentration; a peak read against a trough range is meaningless.
  4. Sample age and storage temperature Capone 2008.
  5. Incomplete red cell lysis, which under-recovers the drug.
  6. Hemolysis or an inadequately mixed EDTA tube Koseoglu 2011.

Reference interval or decision threshold — which kind of number Sirolimus (Rapamycin), Whole Blood is

This is a therapeutic drug monitoring target, derived in transplant recipients, for a purpose most readers of this page do not share. The published trough windows come from studies of graft rejection and drug toxicity in solid organ transplantation. They are outcome-derived, and the outcome is rejection.

The target is method-specific. Because immunoassay reads higher than chromatography, a trough range validated on one method is not the range for the other Salm 2000 Zochowska 2006.

There is no reference interval for a person not taking the drug, and no target concentration has been established for any non-transplant use. Nothing in the monitoring literature defines a concentration associated with a longevity outcome.

Trough concentration is a poor surrogate for exposure on intermittent regimens. The trough-to-area-under-the-curve relationship was established for continuous daily dosing; with weekly or less frequent dosing, a trough measured days after a dose is a point on a decay curve rather than a steady-state value Ivanova 2011.

How you would know your Sirolimus (Rapamycin), Whole Blood was wrong — and when to redraw

Seven days after a dose change, because five half-lives of a 60-hour drug is about 12 days and 5 to 7 days gets most of the way there. Measuring earlier reports a concentration that has not finished accumulating.

Always as a trough, immediately before the next dose, and with the time from the last dose recorded. On an intermittent regimen a level without that timestamp cannot be interpreted at all.

Conditions that must match: the same method — immunoassay and LC-MS/MS results are not interchangeable Salm 2000; the same laboratory; the same time from dose; the same concomitant drugs; and a sample analyzed within the laboratory's stability window Capone 2008.

What would have to change for the second number to mean something:

  • Level higher than expected? Check the interacting drug list and the method before changing anything; an immunoassay result is expected to sit above a chromatographic one Zochowska 2006.
  • Level changed after a laboratory switch? That is the method, not the patient Lorde 2023.
  • Monitoring for adverse effects rather than efficacy? The numbers that move first are the lipid panel — sirolimus raises triglycerides and cholesterol characteristically — plus the CBC for cytopenias and urinalysis for proteinuria.
  • Glucose or wound healing a concern? HbA1c and fasting glucose in the CMP belong on the same schedule, since mTOR inhibition impairs both insulin signaling and healing.
  • Hematocrit changed substantially? The whole-blood concentration will move with it for the same body burden of drug; read the CBC beside the level.

What Sirolimus (Rapamycin), Whole Blood cannot tell you

It cannot tell you whether mTOR is inhibited in a tissue. A blood concentration is not a pharmacodynamic measurement, and the relationship between trough concentration and S6 kinase inhibition in any given tissue has not been established for non-transplant use.

It cannot be compared between methods, and the difference is systematic rather than random Salm 2000 Zochowska 2006.

It cannot be interpreted on an intermittent regimen using transplant reference windows, because those windows describe a different exposure profile Ivanova 2011.

It cannot predict the adverse effects, several of which — mouth ulcers, impaired wound healing, dyslipidemia — occur across the therapeutic range rather than above it.

The wrong inference readers actually draw is that a trough inside a published transplant range means a dose is right for them. Those windows were derived to prevent organ rejection on daily dosing measured by a specific assay, and none of the three assumptions holds for someone taking the drug weekly for something else Ivanova 2011 Salm 2000.

Sources read for these sections

  • Zochowska D, et al. High-performance liquid chromatography versus immunoassay for the measurement of sirolimus: comparison of two methods. Transplantation Proceedings 2006 · PMID 16504669
  • Capone D, et al. Stability of sirolimus and everolimus measured by immunoassay techniques in whole blood samples from kidney transplant patients. International Journal of Immunopathology and Pharmacology 2008 · PMID 18547473
  • Salm P, et al. The quantification of sirolimus by high-performance liquid chromatography-tandem mass spectrometry and microparticle enzyme immunoassay in renal transplant recipients. Clinical Therapeutics 2000 · PMID 10823375
  • Ivanova M, et al. High-throughput LC-MS/MS method for monitoring sirolimus and everolimus in the routine clinical laboratory. Clinical Chemistry and Laboratory Medicine 2011 · PMID 21574883
  • Lorde N, et al. Impact of Variation between Assays and Reference Intervals in the Diagnosis of Endocrine Disorders. Diagnostics (Basel) 2023 · PMID 37998589
  • Koseoglu M, et al. Effects of hemolysis interferences on routine biochemistry parameters. Biochemia Medica 2011 · PMID 22141211

Sirolimus (Rapamycin), Whole Blood questions

5 answered
What is a normal Sirolimus (Rapamycin), Whole Blood level?
Transplant therapeutic ranges 4–20 ng/mL depending on protocol; longevity protocols use intermittent, much lower exposure. Ranges vary by laboratory and assay; always compare to the range printed on your own report.
What is the optimal Sirolimus (Rapamycin), Whole Blood level?
There is no established 'optimal' level for longevity use — that's an honest limitation. Clinical ranges apply to transplant indications. Interpretation belongs to the prescriber; see the result-category block on this page.
What does an abnormal Sirolimus (Rapamycin), Whole Blood result mean?
Immunosuppression, mouth ulcers, impaired wound healing, dyslipidemia, and glucose intolerance.
How often should I retest Sirolimus (Rapamycin), Whole Blood?
Per prescribing physician.
How do I test Sirolimus (Rapamycin), Whole Blood?
Through Marek Diagnostics without a doctor's visit, drawn at a Quest Diagnostics location in the US. Code CAMERON applies 10% off automatically through the links on this page.

Sources: Transplant therapeutic drug monitoring guidance. Mannick JB et al., Sci Transl Med 2014 — mTOR inhibition and immune function in older adults.

Inside Skool · $10/mo

Turn your Sirolimus (Rapamycin), Whole Blood number into a plan

This page tells you what the number means and the order to act in. Skool is where it becomes a plan for your situation, read against your own labs.

  • Supplement form, timing and how long to run it
  • The hormones and compounds that move it, and what to watch
  • Your retest calendar: what to draw, when, and what a change means
Join Skool $10/moCancel anytime

5.0 (15 reviews)1,500+ members

Coach Cam's community on Skool: the public page, with the rating, members and price

Want it built around you?

Educational and research purposes only. Not medical advice; talk to your clinician about results. Lab ranges vary by assay and laboratory: compare against the range printed on your own report. Some links are affiliate links; Cam may earn a commission at no extra cost to you. Medical disclaimer and affiliate disclosure

Order this testJoin Skool